Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta and Pine Land Company, widely known as Deltapine, was a premier American commercial breeder, producer, and marketer of cotton and soybean seeds. Headquartered in Scott, Mississippi, the company was a pioneer in agricultural biotechnology, specifically in the development of transgenic cotton varieties that incorporated traits for herbicide tolerance and insect resistance. The company gained significant international attention for its co-development of Genetic Use Restriction Technology (GURT), colloquially known as "Terminator technology," which was designed to produce sterile seeds. In 2007, the company was acquired by Monsanto for approximately $1.5 billion, a move that consolidated a vast library of cotton germplasm and biotechnology traits under Monsanto's control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta and Pine Land Company.